0pengikut
2004madeg
Babagan Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.
Source: Wikipedia
IndustriBiotechnology
Kantor pusatHayward, CA
Ngadeg2004
Bentuk hukumC Corporation
StatusAktif
Paten1 paten
PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL]OX…JP2011021042A · 2011
Ulasan
Durung ana ulasan. Wis kerja karo Anthera Pharmaceuticals Inc? Dadi sing pisanan mbage pengalaman.
Angka utama
Mlebu kanggo ndeleng angka-angka utama
Pendapatan, bathi resik, lan jumlah karyawan Anthera Pharmaceuticals Inc saben taun, kanthi sumbere.
Mlebu Gawe akun nganggo email sampeyanGratis
Kanthi nerusake, sampeyan setuju karo Perjanjian Pangguna, Kabijakan Privasi, lan Kabijakan Cookie Heelky.
Informasi hukum
| Jeneng hukum | Anthera Pharmaceuticals Inc |
|---|---|
| Bentuk hukum | C Corporation |
| SEC CIK | 1316175Deleng ing SEC EDGAR ↗ |
| Alamat kadhaftar | Hayward, CA |
| Status | Aktif |
Sumber: SEC EDGAR · dianyari Nov. 14, 2026
Kontak & tautan
Lokasi
Hayward, CA
Apa iki perusahaan sampeyan?
Klaim kaca iki gratis kanggo nambah logo, produk, foto, lan kerja, lan kanggo mangsuli ulasan.
Klaim kaca ikiGabung Heelky kanggo nyambung, nyewa, lan tuwuh
Gawe akun gratis kanggo ngirim pesen, nglamar kerja, lan ngirim misi.
Gabung saiki — gratis